|POZEN to Present at the Deutsche Bank Health Care Conference|
CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 27, 2004--POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the Company's chairman, president and chief executive officer, will be speaking to investors at the Deutsche Bank Health Care Conference on Tuesday, May 4, at 9:00 a.m. Eastern Time in Baltimore. Dr. Plachetka's presentation will be webcast live and archived on POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has developed what it believes to be one of the largest and most advanced product pipeline in the field of migraine. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.